Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-051130
Filing Date
2022-09-23
Accepted
2022-09-23 16:10:10
Documents
2
Period of Report
2022-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1633
2 EX-24 DOCUMENT attachment1.htm EX-24 4543
  Complete submission text file 0001209191-22-051130.txt   7642
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 01824
Business Address
Amello Jason (Reporting) CIK: 0001451805 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40629 | Film No.: 221262447

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)